Announcement PDF Appendix 3C - Notification of buy-back Appendix 3C - Notification of buy-back 1 / 5 Announcement Summary Name of entity NEUREN PHARMACEUTICALS LIMITED Announcement type New announcement Date of this announcement 11/2/2026 ASX Security code and description of the class of +securities the subject of the buy-back NEU : ORDINARY FULLY PAID The type of buy-back is: Refer to next page for full details of the announcement On market buy-back Appendix 3C - Notification of buy-back Appendix 3C - Notification of buy-back 2 / 5 Part 1 - Entity and announcement details 1.1 Name of entity NEUREN PHARMACEUTICALS LIMITED We (the entity named above) provide the following information about our buy-back. 1.2 Registration number type ABN Registration number 72111496130 1.3 ASX issuer code NEU 1.4 The announcement is 1.5 Date of this announcement 11/2/2026 1.6 ASX Security code and description of the class of +securities the subject of the buy-back NEU : ORDINARY FULLY PAID New announcement Appendix 3C - Notification of buy-back Appendix 3C - Notification of buy-back 3 / 5 Part 2 - Type of buy-back 2.1 The type of buy-back is: On market buy-back Appendix 3C - Notification of buy-back Appendix 3C - Notification of buy-back 4 / 5 Part 3 - Buy-back details Part 3A - Details of +securities, price and reason 3A.1 Total number of +securities on issue in the class of +securities to be bought back 126,639,526 3A.4 Does the entity intend to buy back a minimum number of +securities 3A.5 Does the entity intend to buy back a maximum number of securities 3A.5a Maximum number of securities proposed to be bought back 6,350,631 3A.6 Name of broker or brokers who will offer to buy back +securities on the entity's behalf Broker name: TBD 3A.9 Are the +securities being bought back for a cash consideration? 3A.9a Is the price to be paid for +securities bought back known? 3A.9a.1 In what currency will the buy-back consideration be paid? AUD - Australian Dollar Part 3B - Buy-back restrictions and conditions 3B.1 Does the buy-back require security holder approval? No No Yes Yes No Appendix 3C - Notification of buy-back Appendix 3C - Notification of buy-back 5 / 5 Part 3C - Key dates On-market buy-back 3C.2 Proposed buy-back start date 2/3/2026 3C.3 Proposed buy-back end date 2/3/2027 Part 3D - Other Information 3D.1 Any other information the entity wishes to notify to ASX about the buy-back